Skip to main content
Egyptian Pediatric Association Gazette
Download PDF

Serum Leptin in Hospitalized Community-Acquired Pneumonia Children under the Age of Five Years

Egyptian Pediatric Association Gazette volume 68, Article number: 7 (2020) Cite this article

Abstract

Background

Community-acquired pneumonia (CAP) accounts for 19% of the world’s total deaths among all age groups yearly, with highest rates in children less than 5 years. This study is designed to evaluate the serum leptin level in hospitalized children under the age of 5 years with CAP.

Results

This prospective cross-sectional study included CAP children under the age of 5 years. Forty-one patients admitted to pediatric intensive care unit (PICU) and 41 patients admitted to general ward were enrolled. Patients with any other cause that may elevate serum leptin were excluded. Serum leptin was measured on the day of admission. The PICU patients had a significantly higher median serum leptin than that of the ward patients (p < 0.001). C-reactive protein (CRP) level was significantly higher in patients with elevated serum leptin than in patients with normal serum leptin (p = 0.001). There was a significant association between high serum leptin and positive sputum cultures (p < 0.001), particularly cultures growing more than one organism (p < 0.001). There was a positive, weak correlation between serum leptin and length of stay (r = 0.30, p = 0.007). Serum leptin showed good discrimination between PICU admissions and inpatient ward admissions (AUC = 0.777, p < 0.001); at a cut-off value of > 29.6 pg/ml, serum leptin had a sensitivity of 70.7% and a specificity of 87.8%

Conclusion

We may conclude that CAP patients with a serum leptin level above 29.6 pg/ml should be considered for PICU admission.

Background

Community-acquired pneumonia (CAP) is a common disease worldwide [1]. It accounts for 19% of the world’s total deaths among all age groups yearly; rates are greatest in children less than 5 years [2].

The national guidelines that were published in 2011, by the Infectious Diseases Society of America (IDSA) and the Pediatric Infectious Disease Society (PIDS) concerning the management of CAP in children, recommended that children with moderate to severe pneumonia should be considered for hospital admission [3].

It is crucial to assess the severity of pneumonia in the emergency department to make a wise decision of either sending the patient home or admitting him in the hospital. Merely few scoring systems for assessment of severity of pneumonia in children are available [4].

Pediatric intensive care units (PICUs) are burdened with high costs and scarcity of available beds [5]; hence, appropriate decisions of PICU admission are indispensable.

Leptin (satiety hormone) is an adipocyte-derived hormone. Its production is associated with total body fat mass. Leptin has a vital role in regulating energy homeostasis as well as innate and adaptive immunity. Blood and tissue leptin levels rise during bacterial infections, contributing to host defense against bacterial pneumonia [6].

Methods

Objectives

The aim of the present study is to:

  • Evaluate the serum leptin level in children with CAP

  • Assess the correlation between serum leptin and pneumonia severity

  • Assess the utility of serum leptin to aid in the early decision of PICU admission in CAP patients

Study design and setting

This prospective cross-sectional study was conducted at University Children’s Hospitals from September 2014 to June 2015.

Patients’ enrollment

Inclusion criteria

The study included 82 children under the age of 5 years with CAP who were admitted either in general pediatric ward or PICU. The decision to admit patients to PICU or inpatient ward was made by the emergency department physicians.

Exclusion criteria

  • Patients with growth percentile more than 95 were excluded

  • Also, patients with upper respiratory tract infections, other acute lower respiratory tract infections apart from pneumonia, or chronic lower respiratory tract infections as tuberculosis were excluded. Patients with chronic systemic illness, oropharyngeal abnormalities, and congenital heart diseases were excluded as well.

Classification of pneumonia severity

The severity of CAP was classified based on the national guidelines that were published by the IDSA and PIDS concerning the management of CAP in children [3]. “Criteria of the moderate CAP are respiratory distress in the form of tachypnea, dyspnea, retractions, grunting, nasal flaring, apnea, altered mental status, or hypoxemia (sustained oxygen saturation of less than 90%).

Criteria of severe CAP was pneumonia requiring invasive ventilation or non-invasive positive pressure ventilation, those having impending respiratory failure, or hypotension or requiring vasopressor support, those having sustained tachycardia and those having persistent pulse oximetry readings of <92% on more than 0.5 liters of oxygen, or having altered mental status, in these patients PICU admission was considered” [3].

The enrolled patients were divided into two equal groups:

  • The PICU group of patients included 41 patients

  • The ward inpatient group included 41 patients

Both study groups were subjected to the following:

  1. 1.

    History and clinical assessment

    1. (a)

      Full clinical history taking with particular emphasis on symptoms of pneumonia. Thorough clinical examination was carried out with detailed cardiac and chest examination. Level of consciousness was evaluated using the Glasgow Coma Scale (GCS).

    2. (b)

      Growth assessment

  2. 2.

    Body measurements (weight and length)

    1. (a)

      For infants less than 2 years of age or above who cannot stand without assistance:

      1. I

        Recumbent length was used to measure their length.

      2. II

        Digital infant scale was used to measure their weight.

    2. (b)

      For children above 2 years of age and can stand without assistance:

      1. I

        Standing height was used to measure their height.

      2. II

        Digital scale was used to measure their weight.

    3. (c)

      We determined the body mass index (BMI) as weight/height2.

    4. (d)

      Body measurements were plotted against appropriate percentile for age and sex

    5. (e)

      In patients less than 24 months old, body weight to length percentile curves were used [7].

    6. (f)

      In patients older than 24 months old, BMI percentile curves were used.

  3. 3.

    Laboratory investigations

    1. (a)

      On the day of admission, basic blood tests were performed including complete blood picture (CBC), C-reactive protein (CRP), and arterial blood gasses (ABG), as well as renal and hepatic function tests. Sputum cultures were also done.

    2. (b)

      Simultaneously, serum leptin samples were withdrawn. Serum leptin was measured using enzyme-linked immunosorbent assay (ELISA). Reference range from zero to 0.036 pg/ml was considered normal values.

Secondary outcome included the length of hospital stay, need of mechanical ventilation (MV), duration of MV, and survival to discharge.

Statistical methods

Data were analyzed using the Statistical Package for Social Sciences software (SPSS), version 22.0 (SPSS Inc., Chicago, IL). Quantitative variables were summarized by mean and standard deviation (SD) for normally distributed data and groups were compared using the Student t test. Variables that did not follow normal distribution were summarized by median and interquartile range (IQR), groups were compared using Mann-Whitney U test, and correlation between variables was assessed using Spearman rank order correlation. Receiver operating characteristic (ROC) curves were constructed to assess the diagnostic ability of serum leptin as regards pneumonia severity and PICU admission. The area under ROC curve (AUC) was graded as follows: 0.90–1 = excellent, 0.80–0.90 = good, 0.70–0.80 = fair, and 0.60–0.70 = poor. For all statistical tests, a p value of < 0.05 was defined as the level of significance.

Results

Characteristics of PICU and ward inpatient groups

Eighty-two children were enrolled in our study. The patients were categorized according to their admission into the PICU and ward inpatient groups; each group included 41 patients. There was no statistically significant difference between the two groups as regards age (p = 0.922), sex (p = 1.000), or growth percentiles (p = 0.274). A significantly higher percentage of PICU patients had severe respiratory distress (p < 0.001), cough (p = 0.012), fever (p = 0.007), and severe degree of pneumonia (p < 0.001) than the ward group. Moreover, median GCS was significantly lower in the PICU group (13 versus 15, p < 0.001). The median serum leptin level on admission was significantly higher in the PICU group than the ward group (235.2 versus 0, p < 0.001). The median CRP level showed similar difference between the two groups (120 versus 11, p = 0.001). Most patients in PICU groups had high leptin and CRP levels (70.7% and 95.1% of cases, respectively) compared to the ward group (14.6% and 61%, respectively). Sputum culture was positive in a significantly higher percentage of PICU group than the ward group (70.7% versus 29.3%, p < 0.001). The hospital stay was significantly longer in the PICU group (15 versus 10 days, p < 0.001). In this study, 31.7% of patients required MV; all of them belonged to PICU group (63.4% of PICU patients). None of the ward inpatients deceased while 7.3% of PICU patients deceased (Table 1 and Fig. 1).

Table 1 Characteristics of the PICU and ward patients
Full size table
Fig. 1
figure1

Relative frequency of patients with high serum leptin and CRP in the studied groups

Full size image

Evaluation of serum leptin

Serum leptin level was above normal values in 35 patients (43.2% of all cases). Comparison between patients with normal leptin level and those with high levels revealed that high leptin level was significantly associated with the severity of respiratory distress (p < 0.001) and the severity of pneumonia (p = 0.009), positive sputum culture (p < 0.001), infection with a single or more than one organism (p < 0.001), and PICU admission (p < 0.001) as well as the need of MV (p = 0.008). In addition, the median CRP level and LOS were significantly longer in patients with high leptin level (p < 0.001) compared to those with normal level (Table 2).

Table 2 Comparison between patients with normal and elevated leptin levels
Full size table

Serum leptin level was significantly higher in patients with severe pneumonia (p = 0.016). However, when the severity of pneumonia was stratified according to the type of admission (Table 3), no significant difference was detected in median serum leptin level between moderate and severe pneumonia, neither in PICU group (p = 0.547) nor in the ward group (p = 0.652).

Table 3 Comparison of serum leptin between different grades of pneumonia severity
Full size table

The correlation between the serum leptin level and CRP and LOS was studied (Table 4). There was a positive strong correlation with CRP when assessed in all patients (rs = 0.810, p < 0.001). The correlation was still positive and significant, though moderate in the PICU (rs = 0.700, p < 0.001) and ward (rs = 0.555, p < 0.001) groups. Serum leptin correlated positively, significantly, and weakly with the duration of hospital stay (rs = 0.295, p = 0.007) when analyzed in the whole sample. When the analysis was repeated for PICU and ward groups separately, the correlation was weak and non-significant (PICU: rs = 0.003, p = 0.986; ward group: rs = 0.171, p = 0.286).

Table 4 Correlation between the serum leptin level, CRP, and length of hospital stay
Full size table

Receiver operating characteristic (ROC) curve analysis was conducted to evaluate the value of serum leptin on admission as an indicator of pneumonia severity and a predictor of PICU admission. As regards pneumonia severity, serum leptin had a fair discriminatory power (AUC = 0.646, 95% CI = 0.532–0.748, p = 0.030). At a cut-off value > 117.6 pg/ml, serum leptin had a sensitivity of 62.1% and a specificity of 73.6% (Fig. 2). As regards the prediction of PICU admission, serum leptin showed good discriminatory power (AUC = 0.777, 95% CI = 0.672–0.861, p < 0.001); at a cut-off value of > 29.6 pg/ml, serum leptin had a sensitivity of 70.7% and a specificity of 87.8% (Fig. 3).

Fig. 2
figure2

ROC for serum leptin to discriminate between moderate and severe pneumonia

Full size image
Fig. 3
figure3

ROC for serum leptin to discriminate between PICU and ward patients

Full size image

Discussion

Pneumonia is considered one of the leading infectious causes of pediatric morbidity and mortality. In 2010, 120 million cases of pneumonia were reported in children younger than 5 years, with 14 million of them proceeding to severe episodes. In 2011, a study estimated that 1.3 million cases of pneumonia deceased and 81% of deaths occurred in the first 2 years of life [8].

Investigating the association of serum leptin and pulmonary diseases in adults attracted a great interest in the past few years. A meta-analysis included ten articles that concluded a positive association between leptin and tumor necrosis factor (TNF-α) levels in COPD exacerbations in adults [9]. Moreover, other studies reported that asthma severity positively correlated with serum leptin [10, 11]. It was suggested that leptin presence is essential for an effective immune response against variable bacterial pulmonary infections [12]. Recently, research proved that leptin has a critical role in the immune system, and its deficiency results in increased severity of pulmonary infections [13]. Therefore, the present study evaluated serum leptin in CAP children.

We found that serum leptin was more elevated in severe cases of pneumonia than moderate cases. However, ROC curve analysis revealed that serum leptin fairly discriminated between moderate and severe pneumonia (AUC = 0.646).

Interestingly, in our study serum leptin showed good discriminatory ability between CAP cases admitted in PICU and those admitted in the general ward. This finding offers a good tool in the emergency department to aid in making a sound objective decision for the appropriate admission location of the patients. Up to the best of the authors’ knowledge, no previous research has studied this point.

In our study, we found a significant association between high serum leptin in the studied patients and sputum cultures growing more than one organism. This was in agreement with Mancuso et al. who reported increased leptin levels in serum, BAL fluid, and whole lung homogenates in response to intra-tracheal challenge with Klebsiella pneumonia in experimental murine models [14] Likewise, another study demonstrated upregulation of pulmonary leptin levels in both humans and mice following bacterial- and viral-induced pneumonia [15].

On the other hand, Al Biltagi et al. found that low serum leptin level was associated with pneumonia in malnourished children [16]. This may be attributed to lower serum leptin in malnourished children than in healthy controls [17, 18]. Hence, malnourished patients were excluded from our study. Another study by Diez et al. reported the lack of significant differences in leptin levels between adult patients hospitalized for community-acquired pneumonia and healthy controls, after adjusting for BMI [19].

We did not find an association between high serum leptin level and mortality from CAP. This finding is in line with comparable studies which concluded that leptin lacks prognostic value for pneumonia lethality [19] and overall all-cause mortality rates in adult males [20].

We found a significantly elevated CRP level in patients with a high serum leptin level. Moreover, the correlation between serum leptin and CRP levels in the studied patients was positive, significant, and strong. Similarly, Somech et al. reported that leptin levels significantly correlated with CRP levels during acute infections in children [21]. Likewise, a research on chronic COPD in adults studied the complex relationship between adipokine metabolism and mild systemic inflammation in chronic COPD and reported the presence of significant correlation between circulating leptin and CRP levels [22].

The present study was subject to few limitations, including the limited number of patients and the non-inclusion of mild cases of CAP as these cases were sent on home treatment from the emergency department.

Conclusion

It can be concluded that cases of pneumonia with serum leptin above normal level are mostly in need of higher level of care after excluding other factors that may increase serum leptin. Serum leptin level above 29.6 pg/ml can fairly differentiate between patients who would be admitted to PICU and in the ward. This finding is a helpful tool in the emergency department to aid in the appropriate location of patients’ admission. However, serum leptin cannot predict CAP mortality.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

ABG:

Arterial blood gasses

AUC:

Area under the curve

BMI:

Body mass index

CAP:

Community-acquired pneumonia (CAP)

CBC:

Complete blood picture

CRP:

C-reactive protein

ELISA:

Enzyme-linked immunosorbent assay

GCS:

Glasgow Coma Scale

IDSA:

Infectious Diseases Society of America

IQR:

Interquartile range

MV:

Mechanical ventilation

PICU:

Pediatric intensive care unit

PIDS:

Pediatric Infectious Disease Society

RD I:

Respiratory distress grade one

RD II:

Respiratory distress grade two

RD III:

Respiratory distress grade three

RD IV:

Respiratory distress grade four

ROC:

Receiver operating characteristic

SD:

Standard deviation

References

  1. 1.

    Ruuskanen O, Lahti E, Jennings LC, Murdoch DR (2011) Viral pneumonia. Lancet. 377(9773):1264–1275. https://doi.org/10.1016/S0140-6736(10)61459-6

    PubMed  Article  Google Scholar 

  2. 2.

    Hahn A, Heffren J, Abo A (2018) Improving evidence based care of community acquired pneumonia in children. Clin Pediatr Emerg Med. 19(1):24–32. https://doi.org/10.1016/j.cpem.2018.02.011

    Article  Google Scholar 

  3. 3.

    Bradley JS, Byington CL, Shah SS et al (2011) Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 53(7):617–630. https://doi.org/10.1093/cid/cir625

    PubMed  PubMed Central  Article  Google Scholar 

  4. 4.

    Miyaji Y, Sugai K, Nozawa A, Kobayashi M, Niwa S (2015) Pediatric Respiratory Severity Score (PRESS) for respiratory tract infections in children. Austin Virol and Retrovirology. 2(2):1009–1001

    Google Scholar 

  5. 5.

    Argent AC (2018) Considerations for assessing the appropriateness of high-cost pediatric care in low-income regions. Front Pediatr. 6:68. https://doi.org/10.3389/fped.2018.00068

    PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Mancuso P, Peters-Golden M, Goel D et al (2011) Disruption of leptin receptor-STAT3 signaling enhances leukotriene production and pulmonary host defense against pneumococcal pneumonia. J Immunol. 186(2):1081–1090. https://doi.org/10.4049/jimmunol.1001470

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    El-Ruby M. Ghalli I, Salah N, Hussien F, Erfan M, El- Ruby M, Mazen I, Sabry M, Abd El-Am Knack Razik M, Saad M, Hossney L, Ismaail S and Abd El-Dayem S et Al. Egyptian Growth Curves 2002 for Infants, Children and Adolescents. Published Aka Sartorio A, Buckler JMH and Marazzi N. Crescere Nel Mondo. Ferring Publisher; 2008;2008.

  8. 8.

    Fischer Walker CL, Rudan I, Liu L et al (2013) Global burden of childhood pneumonia and diarrhoea. Lancet. 381(9875):1405–1416. https://doi.org/10.1016/S0140-6736(13)60222-6

    Article  Google Scholar 

  9. 9.

    Zhou L, Yuan C, Zhang J et al (2014) Circulating leptin concentrations in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respiration. 86(6):512–522. https://doi.org/10.1159/000354191

    CAS  Article  Google Scholar 

  10. 10.

    Newson RB, Jones M, Forsberg B et al (2014) The association of asthma, nasal allergies, and positive skin prick tests with obesity, leptin, and adiponectin. Clin Exp Allergy. 44(2):250–260. https://doi.org/10.1111/cea.12221

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Nasiri Kalmarzi R, Ataee P, Mansori M et al (2017) Serum levels of adiponectin and leptin in asthmatic patients and its relation with asthma severity, lung function and BMI. Allergol Immunopathol (Madr). 45(3):258–264. https://doi.org/10.1016/j.aller.2016.09.004

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Vernooy JHJ, Ubags NDJ, Brusselle GG et al (2013) Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases. Pulm Pharmacol Ther. 26(4):464–472. https://doi.org/10.1016/j.pupt.2013.03.016

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Alti D, Sambamurthy C, Kalangi SK (2018) Emergence of leptin in infection and immunity: scope and challenges in vaccines formulation. Front Cell Infect Microbiol. 8(8):1–18. https://doi.org/10.3389/fcimb.2018.00147

    CAS  Article  Google Scholar 

  14. 14.

    Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB (2002) Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol. 168(8):4018–4024. https://doi.org/10.4049/jimmunol.168.8.4018

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Ubags ND, Vernooy JH, Burg E et al (2014) The role of leptin in the development of pulmonary neutrophilia in infection and acute lung injury. Crit Care Med. 42(2):1–19. https://doi.org/10.1097/CCM.0000000000000048

    CAS  Article  Google Scholar 

  16. 16.

    Al Biltagi M, Baset A, Hagag A, Alogi H (2010) Serum leptin levels among malnourished children with and without pneumonia. J Pediatr Biochem. 1(3):209–215. https://doi.org/10.1055/s-0036-1586376

    Article  Google Scholar 

  17. 17.

    Soliman AT, ElZalabany MM, Salama M, Ansari BM (2000) Serum leptin concentrations during severe protein-energy malnutrition: correlation with growth parameters and endocrine function. Metabolism. 49(7):819–825. https://doi.org/10.1053/meta.2000.6745

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Ece A, Gürkan F, Çelik F et al (2007) Paraoxonase, total antioxidant activity and peroxide levels in marasmic children: relationships with leptin. Clin Biochem. 40(9-10):634–639. https://doi.org/10.1016/j.clinbiochem.2007.03.001

    CAS  PubMed  Article  Google Scholar 

  19. 19.

    Díez ML, Santolaria F, Tejera A et al (2008) Serum leptin levels in community acquired pneumonia (CAP) are related to nutritional status and not to acute phase reaction. Cytokine. 42(2):156–160. https://doi.org/10.1016/j.cyto.2008.02.013

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Amrock SM, Weitzman M (2014) Effect of increased leptin and C-reactive protein levels on mortality: results from the national health and nutrition examination survey. Atherosclerosis 236(1). https://doi.org/10.1016/j.atherosclerosis.2014.06.009

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  21. 21.

    Somech R, Reif S, Golander A, Spirer Z (2007) Leptin and C-reactive protein levels correlate during minor infection in children. Isr Med Assoc J. 9(2):76–78

    CAS  PubMed  Google Scholar 

  22. 22.

    Breyer MK, Rutten EPA, Locantore NW, Watkins ML, Miller BE, Wouters EFM (2012) Dysregulated adipokine metabolism in chronic obstructive pulmonary disease. Eur J Clin Invest. 42(9):983–991. https://doi.org/10.1111/j.1365-2362.2012.02686.x

    CAS  PubMed  Article  Google Scholar 

Download references

Acknowledgements

Not applicable

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Affiliations

  1. Pediatric Department, Kasr AlAiny Faculty of Medicine, Cairo University, Cairo, Egypt

    Heba Abouhussein, Shereen Mohamed & Talal Dougman

  2. Pediatric Intensive Care Unit, Pediatric University Hospital Aboul Elrish, Cairo, Egypt

    Shereen Mohamed

  3. Clinical Pathology Department, Kasr AlAiny Faculty of Medicine, Cairo University, Cairo, Egypt

    Rabab ElHawary

Authors
  1. Heba Abouhussein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shereen Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Talal Dougman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rabab ElHawary
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

HA shared in the study design and approved the manuscript. SM shared in the study design and wrote the manuscript. TD did the patients enrollment and collection of data, RH did the laboratory work and shared in the study design. All authors revised and approved the manuscript and agree to publish it in the Egyptian Pediatric Association Gazette (EPAG).

Corresponding author

Correspondence to Shereen Mohamed.

Ethics declarations

Ethics approval and consent to participate

The Research Ethics Committee of the Faculty of Medicine, Cairo University, approved the protocol (on 5 May 2014) (reference number I-111011). Written consent was obtained from the patients’ guardians.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Abouhussein, H., Mohamed, S., Dougman, T. et al. Serum Leptin in Hospitalized Community-Acquired Pneumonia Children under the Age of Five Years. Egypt Pediatric Association Gaz 68, 7 (2020). https://doi.org/10.1186/s43054-020-0018-2

Download citation

Keywords

  • Serum leptin
  • Community-acquired pneumonia
  • Severity
  • Pediatric intensive care unit
  • Children